Zafirlukast
Zafirlukast is a prescription medication that works as a leukotriene receptor antagonist to help prevent asthma attacks and manage symptoms of allergic rhinitis. Available as oral tablets in 10mg and 20mg strengths, it's manufactured by Dr. Reddy's Laboratories Limited under ANDA090372. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Zafirlukast is a prescription medication that works as a leukotriene receptor antagonist to help prevent asthma attacks and manage symptoms of allergic rhinitis. Available as oral tablets in 10mg and 20mg strengths, it's manufactured by Dr. Reddy's Laboratories Limited under ANDA090372. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Zafirlukast",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Zafirlukast — ANDA 213163 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213163"
}
]
|
| identifier | ANDA213163 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"pharmaceuticals",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Zafirlukast |
